Monica Vajani

Nov 12, 2024 | medcitynews.com | Frank Vinluan |Monica Vajani |Eve McDavid

A Neurogene gene therapy in development for the rare neurodevelopmental disorder Rett syndrome has encouraging early data in a small group of patients, an interim readout that comes a week after a private placement infused the biotech with $200 million to last it the next two years. But investors are focusing on a late-breaking development — a complication experienced by a patient who received the high dose of the experimental one-time treatment.

Nov 11, 2024 | medcitynews.com | Frank Vinluan |Monica Vajani |Eve McDavid

An AbbVie schizophrenia drug acquired as part of a multi-billion dollar deal has failed two mid-stage studies, dealing a setback to the company’s plans to compete with a Bristol Myers Squibb medication that was recently approved in schizophrenia and is projected to become a blockbuster seller across several psychiatric indications.

Nov 8, 2024 | medcitynews.com | Frank Vinluan |Monica Vajani

A pharmaceutical ingredient that’s been a key component in nasal decongestants for decades is having its efficacy called into question, and the FDA is now weighing whether to change the compound’s regulatory status — potentially leading to many widely used over-the-counter cold and allergy products being pulled from pharmacy shelves. But before the FDA takes any action, it wants to hear what the public thinks.

Nov 7, 2024 | medcitynews.com | Katie Adams |Monica Vajani |Stephanie Baum

The healthcare industry is slowly moving away from fee-for-service care models and toward value-based care — but contracting in these arrangements remains especially difficult for behavioral health providers, according to Taft Parsons III, chief psychiatric officer at CVS Health/Aetna. He highlighted this issue during a panel discussion on Tuesday at the Behavioral Health Tech conference in Phoenix.

Nov 7, 2024 | medcitynews.com | Susan Torroella |Stephanie Baum |Monica Vajani

The maternity journey is a path paved with uncertainty. From the moment those two pink lines appear, a mom-to-be faces more questions than answers — and has to quickly identify trusted resources that will mean the best prenatal, delivery, and postnatal care for herself and her baby. Prior to pregnancy, many expecting members have likely not engaged with the healthcare system much, if at all, and are diving headfirst into a realm of the unknown. That’s where a health plan can step in.